Publication

Byline

Location

Experts say Garba during Navratri can double as a cardio workout, share tips on stamina and safety

India, Oct. 15 -- Physiotherapist Lakshya Bhaktyani of PSRI Hospital and Kushal Pal Singh, fitness and performance expert at Anytime Fitness India, have outlined how Garba during Navratri can function... और पढ़ें


Paediatrician Dr Rajiv Chhabra shares five everyday home changes to reduce health risks for children

India, Oct. 15 -- Paediatrician Dr Rajiv Chhabra of Artemis Hospital, Gurugram, shared five everyday changes parents can make at home to reduce preventable health risks for children, according to an H... और पढ़ें


HT Lifestyle articles highlight age-specific nutrition, silent eye conditions, and healthier Navratri fasting meals

India, Oct. 15 -- Hindustan Times Lifestyle reported on guidance shared by wellness and nutrition expert Dr Namita Jain on Oct. 2, 2026, and by ophthalmologist Dr Rishi Bhardwaj on Oct. 15, 2026, alon... और पढ़ें


Oncologists and ophthalmologist outline lesser-known breast cancer warning signs and silent eye conditions

India, Oct. 15 -- Surgical oncologist Dr Naveen Sanchety and ophthalmologist Dr Rishi Bhardwaj, speaking to HT Lifestyle in separate articles updated and published on Oct. 14 and Oct. 15, 2026, descri... और पढ़ें


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4174794 in Participants with Obesity or Overweight who are Otherwise Healthy

Singapore, Oct. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to ... और पढ़ें


Singapore Clinical Trial: A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Singapore, Oct. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Sever... और पढ़ें


Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamide Compared with ARPI or Docetaxel in Patients with Metastatic Castration Resistant Prostate Cancer Previously Treated with Abiraterone Acetate (Himalayas-1)

Singapore, Oct. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutami... और पढ़ें


Singapore Clinical Trial: An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-08634404 in Combination With Chemotherapy Versus Pembrolizumab in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent Mismatch Repair (MMR) Proficient Endometrial Cancer

Singapore, Oct. 15 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-0863... और पढ़ें


Singapore Clinical Trial: A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib (RMC-9805) as First Line Treatment in Patients With Metastatic Non-squamous RAS G12D-Mutated Non-small Cell Lung Cancer (RASolve 308)

Singapore, Oct. 15 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy Wi... और पढ़ें


Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Patients With Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma (RASolute 309)

Singapore, Oct. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Ver... और पढ़ें